SquareMind Raises $18 Million for AI and Robotics Skin Exam Platform

April 28, 2026
SquareMind has raised $18 million to expand its AI and robotics platform for dermatology, with plans to launch its Swan robotic skin imaging system in the United States and Europe.
SquareMind Raises $18 Million for AI and Robotics Skin Exam Platform

SquareMind has raised $18 million in funding to expand its AI and robotics platform for dermatology, announced in a press release. The round was led by Sonder Capital, with participation from the Deeptech 2030 Fund, Adamed Technology, Calm/Storm Ventures, Teampact Ventures, and several entrepreneurs.

The funds will support the growth of SquareMind’s commercial, engineering, and customer support teams as it prepares to launch its Swan robotic skin imaging platform in the United States and Europe. Swan is described as the first robot to capture standardized full body dermoscopic images, automating the process of skin documentation for dermatologists.

Developed with input from dermatology specialists, the Swan system captures images in minutes and integrates with clinical workflows. Its AI-based software helps track new or changing moles over time while maintaining physician oversight.

SquareMind, based in Paris, holds both FDA listing and CE marking for the Swan platform, enabling its commercial use in both markets.

We hope you enjoyed this article.

Consider subscribing to one of our newsletters like Robotics Brief, Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

AI & Robotics Healthcare & Life Sciences AI AI Brief AI Brief (X)

More from: Robotics

04/28
Skydio Commits $3.5 Billion to Expand US Drone Manufacturing
04/28
Reliable Robotics Raises $160 Million to Scale Autonomous Flight Systems
04/28
MOIA America and Beep Partner to Launch Autonomous Transit Fleet in Orlando
04/28
PL-Universe Robotics Debuts Embodied AI Robots at Hannover Messe 2026
04/28
Jtibot Showcases Autonomous Outdoor Sweeper at Interclean Amsterdam 2026

More from: Life Sciences

04/28
Onymos and Mayo Clinic Partner on Intelligent Document Processing for Healthcare
04/28
Verana Health Introduces AI Agent Claire for MIPS Data Submissions
04/28
IMO Health Opens Direct Access to Clinical Knowledge Graph for AI Developers
04/28
Permanente Leaders Recognized for AI and Value Based Care Advances
04/28
Fathom Therapeutics Raises $47 Million to Advance AI Drug Design Platform

Subscribe to AI Funding Brief

AI Token Webinar

Whitepaper

Stanford HAI’s 2025 AI Index Reveals Record Growth in AI Capabilities, Investment, and Regulation

The 2025 AI Index by Stanford HAI provides a comprehensive overview of the global state of artificial intelligence, highlighting significant advancements in AI capabilities, investment, and regulation. The report details improvements in AI performance, increased adoption in various sectors, and the growing global optimism towards AI, despite ongoing challenges in reasoning and trust. It serves as a critical resource for policymakers, researchers, and industry leaders to understand AI's rapid evolution and its implications.

Read more

You May Also Like